BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12034746)

  • 1. Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice.
    Matsumoto H; Ma WG; Daikoku T; Zhao X; Paria BC; Das SK; Trzaskos JM; Dey SK
    J Biol Chem; 2002 Aug; 277(32):29260-7. PubMed ID: 12034746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the preattachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice.
    Song H; Lim H; Das SK; Paria BC; Dey SK
    Mol Endocrinol; 2000 Aug; 14(8):1147-61. PubMed ID: 10935540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation.
    Chakraborty I; Das SK; Dey SK
    J Endocrinol; 1995 Nov; 147(2):339-52. PubMed ID: 7490564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids.
    Chakraborty I; Das SK; Wang J; Dey SK
    J Mol Endocrinol; 1996 Apr; 16(2):107-22. PubMed ID: 9156514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
    Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
    Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy.
    Daikoku T; Matsumoto H; Gupta RA; Das SK; Gassmann M; DuBois RN; Dey SK
    J Biol Chem; 2003 Feb; 278(9):7683-91. PubMed ID: 12482866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
    Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
    Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine angiogenesis during implantation and decidualization in mice.
    Matsumoto H; Sato E
    Reprod Med Biol; 2006 Jun; 5(2):81-86. PubMed ID: 29699239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus.
    Das SK; Chakraborty I; Wang J; Dey SK; Hoffman LH
    Biol Reprod; 1997 Jun; 56(6):1390-9. PubMed ID: 9166690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
    Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
    J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer.
    Cianchi F; Cortesini C; Bechi P; Fantappiè O; Messerini L; Vannacci A; Sardi I; Baroni G; Boddi V; Mazzanti R; Masini E
    Gastroenterology; 2001 Dec; 121(6):1339-47. PubMed ID: 11729113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2: a therapeutic target in angiogenesis.
    Iñiguez MA; Rodríguez A; Volpert OV; Fresno M; Redondo JM
    Trends Mol Med; 2003 Feb; 9(2):73-8. PubMed ID: 12615041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.
    Reese J; Paria BC; Brown N; Zhao X; Morrow JD; Dey SK
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9759-64. PubMed ID: 10944235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
    Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
    Plate KH; Breier G; Weich HA; Mennel HD; Risau W
    Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.
    Banerjee SK; Sarkar DK; Weston AP; De A; Campbell DR
    Carcinogenesis; 1997 Jun; 18(6):1155-61. PubMed ID: 9214597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma.
    Jaeckel EC; Raja S; Tan J; Das SK; Dey SK; Girod DA; Tsue TT; Sanford TR
    Arch Otolaryngol Head Neck Surg; 2001 Oct; 127(10):1253-9. PubMed ID: 11587608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration.
    Sköld M; Cullheim S; Hammarberg H; Piehl F; Suneson A; Lake S; Sjögren A; Walum E; Risling M
    Eur J Neurosci; 2000 Oct; 12(10):3675-86. PubMed ID: 11029637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.